OPK - OPKO Health, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
1.05B
Enterprise Value 3
1.3B
Trailing P/E
N/A
Forward P/E 1
-5.27
PEG Ratio (5 yr expected) 1
-0.31
Price/Sales (ttm)
1.17
Price/Book (mrq)
0.59
Enterprise Value/Revenue 3
1.45
Enterprise Value/EBITDA 6
-9.74

Trading Information

Stock Price History

Beta (5Y Monthly) 2.21
52-Week Change 3-53.31%
S&P500 52-Week Change 325.78%
52 Week High 33.8200
52 Week Low 31.3300
50-Day Moving Average 31.5319
200-Day Moving Average 31.7995

Share Statistics

Avg Vol (3 month) 34.82M
Avg Vol (10 day) 34.9M
Shares Outstanding 5665.6M
Float 407.82M
% Held by Insiders 139.64%
% Held by Institutions 122.77%
Shares Short (Dec 30, 2019) 480.77M
Short Ratio (Dec 30, 2019) 417.96
Short % of Float (Dec 30, 2019) 422.26%
Short % of Shares Outstanding (Dec 30, 2019) 412.14%
Shares Short (prior month Nov 28, 2019) 474.38M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin -30.98%
Operating Margin (ttm)-25.43%

Management Effectiveness

Return on Assets (ttm)-5.89%
Return on Equity (ttm)-16.25%

Income Statement

Revenue (ttm)899.45M
Revenue Per Share (ttm)1.54
Quarterly Revenue Growth (yoy)-8.40%
Gross Profit (ttm)314.61M
EBITDA -133.57M
Net Income Avi to Common (ttm)-278.65M
Diluted EPS (ttm)-0.4780
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)64.67M
Total Cash Per Share (mrq)0.1
Total Debt (mrq)314.16M
Total Debt/Equity (mrq)19.13
Current Ratio (mrq)1.08
Book Value Per Share (mrq)2.67

Cash Flow Statement

Operating Cash Flow (ttm)-161.14M
Levered Free Cash Flow (ttm)-67.54M